Results 311 to 320 of about 565,685 (338)
Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III
, 2021 Pierre Péterlin, Pascal Turlure, Philippe Chevallier, Marie Pierre Gourin, Pamela Dumas, Sylvain Thépot, Anna Berceanu, S. Park, Marie Anne Hospital, Thomas Cluzeau, J.-M. Torregrossa-Diaz, Louis Devron, Rosa Sapena, Fatiha Chermat, Sophie Dimicoli‐Salazar, Pierre Fenaux +15 moreopenalex +2 more sourcesTopic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: SELECT-MDS-1 TRIAL IN PROGRESS: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TAMIBAROTENE/AZACITIDINE VS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED (ND) ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS
, 2023 A. Dezern, P. Fenaux, D. Deeren, M. Campelo, M. Lübbert, P. Krishnamurthy, Z. Nagy, G. Basak, A. Jonasova, K. Geissler, Y. Ofran, V. Klimek, A. Volkert, J. Chisholm, B. Hu, G. Hodgson, D.A. Roth, M. Kelly, G. Marconi +18 moreopenalex +1 more sourceTopic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: PEVAZ: A PHASE II STUDY OF PEVONEDISTAT AND AZACITIDINE IN MDS AND MDS/MPN PATIENTS RELAPSED OR REFRACTORY TO DNMT INHIBITION (DNMTI)
, 2023 J. Watts, B. Smith, T. Bradley, B. Skikne, J. Mendler, V. Klimek, A. Thomassen, T. Stopcyzinski, Sichu Chen, F. Run, I. Anderson, A. Moncrief, S. Madhu, A. Sochacki, A. Kishtagari, S. Strickland, M. Byrne, Gerry Ayers, S. Mohan, T. Moyo, M. Savona +20 moreopenalex +1 more sourceSome of the next articles are maybe not open access.Related searches: